Related references
Note: Only part of the references are listed.Design of lipid-based nanoparticles for delivery of therapeutic nucleic acids
Monique C. P. Mendonca et al.
DRUG DISCOVERY TODAY (2023)
Hydrogels for RNA delivery
Ruibo Zhong et al.
NATURE MATERIALS (2023)
Epitopes screening and vaccine molecular design of SADS-CoV based on immunoinformatics
Shinian Li et al.
FRONTIERS IN VETERINARY SCIENCE (2023)
Integrated mRNA sequence optimization using deep learning
Haoran Gong et al.
BRIEFINGS IN BIOINFORMATICS (2023)
Development of mRNA Vaccines/Therapeutics and Their Delivery System
Sora Son et al.
MOLECULES AND CELLS (2023)
The Repertoire of RNA Modifications Orchestrates a Plethora of Cellular Responses
Panagiotis G. Adamopoulos et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
The impact of the gut microbiome on extra-intestinal autoimmune diseases
Eiji Miyauchi et al.
NATURE REVIEWS IMMUNOLOGY (2023)
Chemistry of Lipid Nanoparticles for RNA Delivery Published as part of the Accounts of Chemical Research special issue mRNA Therapeutics
Gaurav Sahay et al.
ACCOUNTS OF CHEMICAL RESEARCH (2022)
Machine Learning for Designing Next-Generation mRNA Therapeutics
Sebastian M. Castillo-Hair et al.
ACCOUNTS OF CHEMICAL RESEARCH (2022)
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
Wilfredo F. Garcia-Beltran et al.
CELL (2022)
SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans
Philip A. Mudd et al.
CELL (2022)
Comparison of mRNA-1273 and BNT162b2 Vaccines on Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Death During the Delta-Predominant Period
Lindsey Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants
Emma K. Accorsi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine
Makda S. Gebre et al.
NATURE (2022)
Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in US Veterans
Barbra A. Dickerman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar
Laith J. Abu-Raddad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine-elicited human sera
Alexander Muik et al.
SCIENCE (2022)
Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study
Massimo Fabiani et al.
BMJ-BRITISH MEDICAL JOURNAL (2022)
Nanomedicine for brain cancer
Sabina Quader et al.
ADVANCED DRUG DELIVERY REVIEWS (2022)
Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine
Rishi R. Goel et al.
CELL (2022)
mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron
Matthew Gagne et al.
CELL (2022)
Recent Advances in Modified Cap Analogs: Synthesis, Biochemical Properties, and mRNA Based Vaccines
Muthian Shanmugasundaram et al.
CHEMICAL RECORD (2022)
The Impact of mRNA Technology in Regenerative Therapy: Lessons for Oral Tissue Regeneration
W. Wisitrasameewong et al.
JOURNAL OF DENTAL RESEARCH (2022)
Contemporary RNA Therapeutics for Glioblastoma
Kaitlyn Melnick et al.
NEUROMOLECULAR MEDICINE (2022)
Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost
Frauke Muecksch et al.
NATURE (2022)
Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age
C. Buddy Creech et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar
L. J. Abu-Raddad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Demystifying mRNA vaccines: an emerging platform at the forefront of cryptic diseases
Nusrat Zahan Rouf et al.
RNA BIOLOGY (2022)
Recent advances of nanodrug delivery system in the treatment of hematologic malignancies
Qianling Ye et al.
SEMINARS IN CANCER BIOLOGY (2022)
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study
Adam S. Lauring et al.
BMJ-BRITISH MEDICAL JOURNAL (2022)
Development of an mRNA replacement therapy for phenylketonuria
Carlos G. Perez-Garcia et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2022)
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes
Claudia P. Arevalo et al.
SCIENCE (2022)
Epitranscriptomics in parasitic protists: Role of RNA chemical modifications in posttranscriptional gene regulation
Cassandra Catacalos et al.
PLOS PATHOGENS (2022)
Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses
Norbert Pardi et al.
NATURE COMMUNICATIONS (2022)
Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study
Ramandip Grewal et al.
BMJ-BRITISH MEDICAL JOURNAL (2022)
mRNA vaccines: Past, present, future
Mia Karam et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2022)
The Pivotal Role of Chemical Modifications in mRNA Therapeutics
Albert Liu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)
Recent advances in therapeutic strategies for triple-negative breast cancer
Yun Li et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)
Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses
Meagan McMahon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
Chutamath Sittplangkoon et al.
FRONTIERS IN IMMUNOLOGY (2022)
Phenylalanine hydroxylase mRNA rescues the phenylketonuria phenotype in mice
Maximiliano L. Cacicedo et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)
Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials
Yuncong Shi et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)
mRNA-based therapeutics: powerful and versatile tools to combat diseases
Shugang Qin et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)
Advances in COVID-19 mRNA vaccine development
Enyue Fang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)
Adjuvant-pulsed mRNA vaccine nanoparticle for immunoprophylactic and therapeutic tumor suppression in mice
Mohammad Ariful Islam et al.
BIOMATERIALS (2021)
Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
Eryn Blass et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
Christina Krienke et al.
SCIENCE (2021)
Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
Fatima Rizvi et al.
NATURE COMMUNICATIONS (2021)
Nanomaterial Delivery Systems for mRNA Vaccines
Michael D. Buschmann et al.
VACCINES (2021)
BMP-2 and VEGF-A modRNAs in collagen scaffold synergistically drive bone repair through osteogenic and angiogenic pathways
Yingnan Geng et al.
COMMUNICATIONS BIOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
A multiclade env-gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques
Peng Zhang et al.
NATURE MEDICINE (2021)
mRNA vaccine for cancer immunotherapy
Lei Miao et al.
MOLECULAR CANCER (2021)
mRNA in cancer immunotherapy: beyond a source of antigen
Lien Van Hoecke et al.
MOLECULAR CANCER (2021)
The Past, the Present, and the Future of the Size Exclusion Chromatography in Extracellular Vesicles Separation
Hussein Kaddour et al.
VIRUSES-BASEL (2021)
Immunomodulating Therapies in Breast Cancer-From Prognosis to Clinical Practice
Marcus Schmidt et al.
CANCERS (2021)
Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza
Sudha Chivukula et al.
NPJ VACCINES (2021)
mRNA-Based Cancer Vaccines: A Therapeutic Strategy for the Treatment of Melanoma Patients
Maryam Bidram et al.
VACCINES (2021)
RNA-based therapies: A cog in the wheel of lung cancer defense
Parvez Khan et al.
MOLECULAR CANCER (2021)
A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice
Ruklanthi de Alwis et al.
MOLECULAR THERAPY (2021)
mRNA vaccines manufacturing: Challenges and bottlenecks
Sara Sousa Rosa et al.
VACCINE (2021)
Exploiting Tumor Neoantigens to Target Cancer Evolution: Current Challenges and Promising Therapeutic Approaches
Ravi G. Gupta et al.
CANCER DISCOVERY (2021)
mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents
Susanne Rauch et al.
NPJ VACCINES (2021)
From Design to Clinic: Engineered Nanobiomaterials for Immune Normalization Therapy of Cancer
Madiha Saeed et al.
ADVANCED MATERIALS (2021)
Mathematical Model Predicts that Acceleration of Diabetic Wound Healing is Dependent on Spatial Distribution of VEGF-A mRNA (AZD8601)
S. Michaela Rikard et al.
CELLULAR AND MOLECULAR BIOENGINEERING (2021)
Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response
Tong Fu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Prostate cancer
Shahneen Sandhu et al.
LANCET (2021)
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
Namit Chaudhary et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Pre-existing immunity to cytomegalovirus in macaques influences human CMV vaccine responses in preclinical models
Helen Webster et al.
VACCINE (2021)
Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 A phase 1 randomized clinical trial
Peter G. Kremsner et al.
WIENER KLINISCHE WOCHENSCHRIFT (2021)
mRNA therapy restores euglycemia and prevents liver tumors in murine model of glycogen storage disease
Jingsong Cao et al.
NATURE COMMUNICATIONS (2021)
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema
Daniel Szoke et al.
NATURE COMMUNICATIONS (2021)
Phenylketonuria
Francjan J. van Spronsen et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
mRNA-Based Anti-TCR CDR3 Tumour Vaccine for T-Cell Lymphoma
Marina Tusup et al.
PHARMACEUTICS (2021)
Long-term stability and protection efficacy of the RBD-targeting COVID-19 mRNA vaccine in nonhuman primates
Hui Zhao et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy
Tianyu Tang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
A guide to vaccinology: from basic principles to new developments
Andrew J. Pollard et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19
Ronen Alon et al.
NATURE REVIEWS IMMUNOLOGY (2021)
A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults
Antonios O. Aliprantis et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)
Tailoring mRNA Vaccine to Balance Innate/Adaptive Immune Response
Sergio Linares-Fernandez et al.
TRENDS IN MOLECULAR MEDICINE (2020)
Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization
Cody S. Nelson et al.
JOURNAL OF VIROLOGY (2020)
TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma
Brenda De Keersmaecker et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Opportunities and Challenges in the Delivery of mRNA-Based Vaccines
Abishek Wadhwa et al.
PHARMACEUTICS (2020)
The promise of mRNA vaccines: a biotech and industrial perspective
Nicholas A. C. Jackson et al.
NPJ VACCINES (2020)
Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection
Amy S. Espeseth et al.
NPJ VACCINES (2020)
Cell entry mechanisms of SARS-CoV-2
Jian Shang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Priorities for developing respiratory syncytial virus vaccines in different target populations
Simon B. Drysdale et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Current Status of Zika Virus Vaccines: Successes and Challenges
Aryamav Pattnaik et al.
VACCINES (2020)
A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases
Yanina Jansen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
A Thermostable mRNA Vaccine against COVID-19
Na-Na Zhang et al.
CELL (2020)
Current Challenges in Vaccinology
Richard B. Kennedy et al.
FRONTIERS IN IMMUNOLOGY (2020)
Single-dose mRNA therapy via biomaterial-mediated sequestration of overexpressed proteins
Andrew S. Khalil et al.
SCIENCE ADVANCES (2020)
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
Kizzmekia S. Corbett et al.
NATURE (2020)
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
Mark J. Mulligan et al.
NATURE (2020)
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
Ugur Sahin et al.
NATURE (2020)
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
Kizzmekia S. Corbett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
DNA-based fluorescent probes of NOS2 activity in live brains
Aneesh T. Veetil et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Immunogenicity generated by mRNA vaccine encoding VZV gE antigen is comparable to adjuvanted subunit vaccine and better than live attenuated vaccine in nonhuman primates
Morgan A. Monslow et al.
VACCINE (2020)
mRNA Vaccine Era-Mechanisms, Drug Platform and Clinical Prospection
Shuqin Xu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer
Gal Cafri et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: The impact of cationic lipid selection
Gustavo Lou et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
Edward E. Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
E. J. Anderson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Dual mRNA therapy restores metabolic function in long-term studies in mice with propionic acidemia
Lei Jiang et al.
NATURE COMMUNICATIONS (2020)
Therapeutic vaccines for colorectal cancer: The progress and future prospect
Mina Shahnazari et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
The trinity of COVID-19: immunity, inflammation and intervention
Matthew Zirui Tay et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Toll-like receptor 7/8-matured RNA-transduced dendritic cells as post-remission therapy in acute myeloid leukaemia: results of a phase I trial
Felix S. Lichtenegger et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)
An Improved, Chemically Modified RNA Encoding BMP-2 Enhances Osteogenesis In Vitro and In Vivo
Wen Zhang et al.
TISSUE ENGINEERING PART A (2019)
A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer
Martin Sebastian et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Phenylketonuria: Current Treatments and Future Developments
Uta Lichter-Konecki et al.
DRUGS (2019)
How mRNA therapeutics are entering the monoclonal antibody field
Lien Van Hoecke et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases
Giulietta Maruggi et al.
MOLECULAR THERAPY (2019)
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
Piotr S. Kowalski et al.
MOLECULAR THERAPY (2019)
Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer
Alexandros Papachristofilou et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
A phase I multicenter study to assess the safety, tolerability, and immunogenicity of mRNA-4157 alone in patients with resected solid tumors and in combination with pembrolizumab in patients with unresectable solid tumors.
Howard A. Burris et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Immunogenicity and tolerability of personalized mRNA vaccine mRNA-4650 encoding defined neoantigens expressed by the autologous cancer.
Gal Cafri et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Clinical and biochemical footprints of inherited metabolic diseases. II. Metabolic liver diseases
Carlos R. Ferreira et al.
MOLECULAR GENETICS AND METABOLISM (2019)
Systematic literature review and meta-analysis on the epidemiology of methylmalonic acidemia (MMA) with a focus on MMA caused by methylmalonyl-CoA mutase (mut) deficiency
Timea Almasi et al.
ORPHANET JOURNAL OF RARE DISEASES (2019)
mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
Robert A Feldman et al.
VACCINE (2019)
Emerging gene therapies for cystic fibrosis
Kamran M. Miah et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2019)
Long-term efficacy and safety of mRNA therapy in two murine models of methylmalonic acidemia
Ding An et al.
EBIOMEDICINE (2019)
Recent advances in polymeric materials for the delivery of RNA therapeutics
David Ulkoski et al.
EXPERT OPINION ON DRUG DELIVERY (2019)
mRNA cap regulation in mammalian cell function and fate
Alison Galloway et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2019)
mRNA as novel technology for passive immunotherapy
Thomas Schlake et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
A bioactive collagen membrane that enhances bone regeneration
Behnoush Khorsand et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS (2019)
Hybrid nanovaccine for the co-delivery of the mRNA antigen and adjuvant
Jingnan Yang et al.
NANOSCALE (2019)
The evolution of seasonal influenza viruses
Velislava N. Petrova et al.
NATURE REVIEWS MICROBIOLOGY (2018)
Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies
Robert L. Bowman et al.
CELL STEM CELL (2018)
Lipid Nanoparticle-Delivered Chemically Modified mRNA Restores Chloride Secretion in Cystic Fibrosis
Ema Robinson et al.
MOLECULAR THERAPY (2018)
Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency
Mary G. Prieve et al.
MOLECULAR THERAPY (2018)
mRNA vaccines - a new era in vaccinology
Norbert Pardi et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Epidemiology of Brain Tumors
Jill S. Barnholtz-Sloan et al.
NEUROLOGIC CLINICS (2018)
Arginase I mRNA therapy - a novel approach to rescue arginase 1 enzyme deficiency
Kirtika H. Asrani et al.
RNA BIOLOGY (2018)
Personalized vaccines for cancer immunotherapy
Ugur Sahin et al.
SCIENCE (2018)
Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity
Shinu John et al.
VACCINE (2018)
Combination treatment of advanced pancreatic cancer using novel vaccine and traditional therapies
Hiroto Matsui et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2018)
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Spencer L. G. James et al.
LANCET (2018)
Structural and molecular mechanisms for the control of eukaryotic 5 '-3 ' mRNA decay
Jeffrey S. Mugridge et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems
S. Guan et al.
GENE THERAPY (2017)
ICTV Virus Taxonomy Profile: Pneumoviridae
Bert Rima et al.
JOURNAL OF GENERAL VIROLOGY (2017)
Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015
Gregory A. Roth et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
Martin Alberer et al.
LANCET (2017)
Propionyl-CoA carboxylase - A review
Parith Wongkittichote et al.
MOLECULAR GENETICS AND METABOLISM (2017)
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
Kapil Bahl et al.
MOLECULAR THERAPY (2017)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
Norbert Pardi et al.
NATURE (2017)
Type I lnterferons Modulate CD8+ T Cell Immunity to mRNA Vaccines
Ans De Beuckelaer et al.
TRENDS IN MOLECULAR MEDICINE (2017)
Systemic Messenger RNA Therapy as a Treatment for Methylmalonic Acidemia
Ding An et al.
CELL REPORTS (2017)
Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines
Johannes Lutz et al.
NPJ VACCINES (2017)
Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia
Sebastien Anguille et al.
BLOOD (2017)
Immune Responses and Long-Term Disease Recurrence Status After Telomerase-Based Dendritic Cell Immunotherapy in Patients With Acute Myeloid Leukemia
Hanna J. Khoury et al.
CANCER (2017)
Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease
Justin M. Richner et al.
CELL (2017)
A Comparative Study of the Bone Regenerative Effect of Chemically Modified RNA Encoding BMP-2 or BMP-9
Behnoush Khorsand et al.
AAPS JOURNAL (2017)
Modified mRNA Vaccines Protect against Zika Virus Infection
Justin M. Richner et al.
CELL (2017)
The Eighth Edition Lung Cancer Stage Classification
Frank C. Detterbeck et al.
CHEST (2017)
Chemically modified RNA induces osteogenesis of stem cells and human tissue explants as well as accelerates bone healing in rats
Elizabeth R. Balmayor et al.
BIOMATERIALS (2016)
Emerging Role of Zika Virus in Adverse Fetal and Neonatal Outcomes
Alice Panchaud et al.
CLINICAL MICROBIOLOGY REVIEWS (2016)
Methylmalonic and propionic acidemias: clinical management update
Jamie L. Fraser et al.
CURRENT OPINION IN PEDIATRICS (2016)
Immunization of HIV-1-Infected Persons With Autologous Dendritic Cells Transfected With mRNA Encoding HIV-1 Gag and Nef: Results of a Randomized, Placebo-Controlled Clinical Trial
Rajesh T. Gandhi et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2016)
Materials for non-viral intracellular delivery of messenger RNA therapeutics
Kevin J. Kauffman et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Epidemiology of Brain Tumors
Katharine A. McNeill
NEUROLOGIC CLINICS (2016)
T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
Eric Tran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs
Margit Schnee et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Varicella-Zoster Virus Glycoproteins: Entry, Replication, and Pathogenesis
Stefan L. Oliver et al.
CURRENT CLINICAL MICROBIOLOGY REPORTS (2016)
Dendritic cells transfected with heat-shock protein 70 messenger RNA for patients with hepatitis C virus-related hepatocellular carcinoma: a phase 1 dose escalation clinical trial
Yoshinari Maeda et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
A novel RNA-based adjuvant combines strong immunostimulatory capacities with a favorable safety profile
Regina Heidenreich et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Chemically modified RNA activated matrices enhance bone regeneration
Satheesh Elangovan et al.
JOURNAL OF CONTROLLED RELEASE (2015)
mRNA: Fulfilling the Promise of Gene Therapy
Drew Weissman et al.
MOLECULAR THERAPY (2015)
Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals
Andreas Thess et al.
MOLECULAR THERAPY (2015)
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
Duane A. Mitchell et al.
NATURE (2015)
Toll-like receptor 8 senses degradation products of single-stranded RNA
Hiromi Tanji et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Toll-like receptor 8 senses degradation products of single-stranded RNA
Hiromi Tanji et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Prophylactic mRNA Vaccination against Allergy Confers Long-Term Memory Responses and Persistent Protection in Mice
E. Hattinger et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
Mutanome Engineered RNA Immunotherapy (MERIT)
Ugur Sahin et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2015)
Varicella zoster virus infection
Anne A. Gershon et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
The ReNAissanCe of mRNA-based cancer therapy
Sandra Van Lint et al.
EXPERT REVIEW OF VACCINES (2015)
Regulation of antiviral T cell responses by type I interferons
Josh Crouse et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Optimized dendritic cell-based immunotherapy for melanoma: the TriMix-formula
Sandra Van Lint et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Ribonucleic acid purification
R. Martins et al.
JOURNAL OF CHROMATOGRAPHY A (2014)
mRNA-based therapeutics - developing a new class of drugs
Ugur Sahin et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Measures of Outcome in Metastatic Breast Cancer: Insights From a Real-World Scenario
Marta Bonotto et al.
ONCOLOGIST (2014)
mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancer
Steffen Rausch et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients
S. Wilgenhof et al.
ANNALS OF ONCOLOGY (2013)
Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
Einar Osland Vik-Mo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
The Silent Global Burden of Congenital Cytomegalovirus
Sheetal Manicklal et al.
CLINICAL MICROBIOLOGY REVIEWS (2013)
Delivery materials for siRNA therapeutics
Rosemary Kanasty et al.
NATURE MATERIALS (2013)
Generation of CTL responses against pancreatic cancer in vitro using dendritic cells co-transfected with MUC4 and survivin RNA
Jiang Chen et al.
VACCINE (2013)
A novel, disruptive vaccination technology Self-adjuvanted RNActive® vaccines
Karl-Josef Kallen et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Cationic lipids activate intracellular signaling pathways
Caroline Lonez et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4+ and CD8+ T Cells Responses in Stage III and IV Melanoma Patients
Erik H. J. G. Aarntzen et al.
CLINICAL CANCER RESEARCH (2012)
Glycogen storage disease type Ia: Linkage of glucose, glycogen, lactic acid, triglyceride, and uric acid metabolism
Sakine Sever et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2012)
Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection
Benjamin Petsch et al.
NATURE BIOTECHNOLOGY (2012)
Conventional and unconventional mechanisms for capping viral mRNA
Etienne Decroly et al.
NATURE REVIEWS MICROBIOLOGY (2012)
hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes
Else M. Inderberg Suso et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Messenger RNA-based Vaccines With Dual Activity Induce Balanced TLR-7 Dependent Adaptive Immune Responses and Provide Antitumor Activity
Mariola Fotin-Mleczek et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Induction of cytotoxic T lymphocytes primed with Tumor RNA-loaded Dendritic Cells in esophageal squamous cell carcinoma: preliminary step for DC vaccine design
Mehran Gholamin et al.
BMC CANCER (2010)
Prophylactic mRNA vaccination against allergy
Richard Weiss et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination
Viggo F. Van Tendeloo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Genome-Wide Mutagenesis Reveals That ORF7 Is a Novel VZV Skin-Tropic Factor
Zhen Zhang et al.
PLOS PATHOGENS (2010)
Nonviral Vectors for Gene Delivery
Meredith A. Mintzer et al.
CHEMICAL REVIEWS (2009)
Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trial
Ann Van Driessche et al.
CYTOTHERAPY (2009)
Immunize and disappear-Safety-optimized mRNA vaccination with a panel of 29 allergens
Elisabeth Roesler et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients
Benjamin Weide et al.
JOURNAL OF IMMUNOTHERAPY (2009)
A novel immunotherapy to hepatocellular carcinoma: CD40-activated B lymphocytes transfected with AFPmRNA
Yafeng Wan et al.
MEDICAL HYPOTHESES (2009)
Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
Katalin Kariko et al.
MOLECULAR THERAPY (2008)
Modification of CEA with both CRT and TAT PTD induces potent anti-tumor immune responses in RNA-pulsed DC vaccination
Sung-Guh Kim et al.
VACCINE (2008)
Role of poly (A) tail as an identity element for mRNA nuclear export
Hiroyuki Fuke et al.
NUCLEIC ACIDS RESEARCH (2008)
Improved native affinity purification of RNA
Robert T. Batey et al.
RNA (2007)
T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells
Jon Amund Kyte et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA
J. A. Kyte et al.
CANCER GENE THERAPY (2006)
Induction of cytotoxic T-lymphocyte responses using dendritic cells transfected with hepatocellular carcinoma mRNA
B-G. Peng et al.
BRITISH JOURNAL OF BIOMEDICAL SCIENCE (2006)
Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism
D Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Washing our hands of the congenital cytomegalovirus disease epidemic
MJ Cannon et al.
BMC PUBLIC HEALTH (2005)
Evaluation of dendritic cells loaded with apoptotic cancer cells or expressing tumour mRNA as potential cancer vaccines against leukemia -: art. no. 20
S Jarnjak-Jankovic et al.
BMC CANCER (2005)
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
F Heil et al.
SCIENCE (2004)
Apoptotic tumor cells are superior to tumor cell lysate, and tumor cell RNA in induction of autologous T cell response in B-CLL
P Kokhaei et al.
LEUKEMIA (2004)
Tumor mRNA-loaded dendritic cells elicit tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma
T Kobayashi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2003)
Synthesis and application of a chain-terminating dinucleotide mRNA cap analog
ZH Peng et al.
ORGANIC LETTERS (2002)